WASHINGTON — Well-liked weight reduction medicine like Ozempic and Wegovy have been added to Medicare’s listing of medicines that shall be negotiated straight between the federal government and drug producers, the Biden administration stated Friday.
The value negotiations for the extra 15 medicine chosen shall be dealt with by the incoming Trump administration and virtually assures billions of {dollars} in financial savings for taxpayers.
Ozempic and Wegovy are made by Novo Nordisk, which is predicated in Denmark and has U.S. headquarters Plainsboro, New Jersey.
